Creating AI to simulate biology and improve the lives of patients
Science First
Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.
A Culture of Precision
Statistical rigor and clinical excellence drive us. We are impacting patient lives, and we hold ourselves to the highest standards.
Trusted Innovator
We are working diligently towards validated innovation. We ensure our products address our customers' exact needs while mitigating risk.
Culture and team
Unlearn was started to solve hard problems. We foster an environment and culture that empowers everyone to do their best work, so we can find solutions together.
Moneyball Medicine Podcast #49: Charles Fisher on Using Digital Twins to Speed Clinical Trials
October 29, 2020
By comparing a patient’s actual record to their Digital Twin, Unlearn can estimate the treatment effect at the patient level and conduct trials with fewer patients.
Unlearn.AI Announces Series A Extension with New Investment from Epic Ventures, Alumni Ventures Group, and Global Pharma Company Eisai
November 5, 2020
Eisai has joined the company’s world-class syndicate of investors as part of its Series A extension along with Epic Ventures and Alumni Ventures Group.
